pfizer biontech - Search News

News

FDA, Pfizer and COVID-19 vaccine

FDA may revoke Pfizer COVID-19 vaccine authorization for kids under certain age

The Food and Drug Administration could pull Pfizer's coronavirus vaccine emergency authorization for children under age 5.

USA TODAY on MSN · 7h

FDA may revoke Pfizer COVID-19 shot for young, healthy children.

Parents won't be able to vaccinate healthy children 6 months to 5 years old if the FDA pulls Pfizer's COVID-19 vaccine authorization.

Seeking Alpha on MSN · 1d

Pfizer/BioNTech may not win FDA renewal for pediatric COVID shot: report

The U.S. Food and Drug Administration (FDA) is unlikely to renew the authorization granted to use Pfizer (NYSE:PFE) and BioNTech’s (BNTX) COVID-19 vaccine in young children this fall, The Guardian reported,

NBC News4y

Pfizer, BioNTech ask FDA for full approval of Covid-19 vaccine

Pfizer-BioNTech has applied for full approval of its Covid-19 vaccine with the FDA. The vaccine would be the first Covid-19 vaccine approved for use in the U.S.

pharmaphorum5d

GSK and CureVac settle mRNA patent spat with Pfizer/BioNTech

The complicated legal wrangling has been brought to a close after CureVac and BioNTech settled their mRNA patent litigation ...

12don MSN

Pfizer, BioNTech lose UK appeal to overturn Moderna's COVID vaccine patent win

Pfizer and its German partner BioNTech on Friday lost their bid to overturn a ruling that their COVID-19 vaccine infringed ...

The Manila Times on MSN11d

Pfizer and BioNTech lose UK court appeal over Covid-19 jab

Pfizer says it will appeal the Aug 1 ruling to Britain’s Supreme Court. Read more at straitstimes.com. Read more at ...

Business Wire5y

Pfizer and BioNTech to Co-Develop Potential COVID-19 Vaccine

This release contains forward-looking information about Pfizer’s efforts to combat COVID-19, BioNTech’s potential COVID-19 mRNA vaccine, BNT162, a letter of intent regarding the co-development ...

The Motley Fool4y

Better Buy: Pfizer vs. BioNTech - The Motley Fool

Pfizer (PFE-1.64%) and BioNTech (BNTX-1.15%) together pulled off one of the greatest accomplishments in medical history by developing a safe and highly effective COVID-19 vaccine in only a matter ...

5don MSN

CureVac and GSK settle mRNA patent dispute with Pfizer and BioNTech

Germany's CureVac and Britain's GSK have settled a years-long patent dispute with Pfizer and its partner BioNTech over the ...

Results that may be inaccessible to you are currently showing.

Hide inaccessible results